A series of new steroidal mono-and bis(thiosemicarbazones) (2a-e and 3a-e) and corresponding monoand bis(1,3,4-thiadiazolines) (4a-e and 5a-e) was synthesized, characterized and evaluated for their anticancer activity. Detailed NMR analysis of the mono-and bis(thiosemicarbazones) revealed the presence of two stereoisomers (Z and E) with different configurations in the hydrazone moiety at the C-3 position, where the substituents on the C(3)]N double bond in the main isomers adopted the E configuration. The configurations at C-3 and C-17 in thiadiazolines 4a-e and 5a-e were deduced by detailed NMR analysis as well as by the examination of Dreiding molecular models and X-ray analysis of 3-thiadiazoline 4a, which confirmed the structure and absolute configuration at C-3. The synthesized compounds were tested against six cancer cell lines (HeLa, K562, MDA-MB-361, MDA-MB-453, LS174 and A549), the normal human cell line MRC-5 and peripheral blood mononuclear cells (PBMC) isolated from healthy donors. The best activity was exhibited by 3-thiosemicarbazones 2a, 2b, 2c and 2e and 3,17-bis(thiadiazolines) 5a and 5d. Examination of the mechanisms of cytotoxicity on cervical adenocarcinoma HeLa cells revealed the pro-apoptotic action of these compounds, which triggered both extrinsic and intrinsic apoptotic pathways. These compounds also showed the ability to decrease angiogenesis in vitro. In addition, 3,17-bis(thiadiazolines) 5a and 5d showed high selectivity in anticancer activity against all the examined malignant cell lines. Compound 5a displayed prominent anticancer potential. The tested compounds showed poor antimicrobial activity.
Introduction
Modications of the steroid backbone that cause changes in its physiological activity leading to the creation of new, biologically active molecules have become one of the main objectives of today's steroid chemistry. Transformations of the steroidal skeleton involving the introduction of heteroatoms and formation of heterocyclic moieties have received much attention in view of the different and interesting biological activities that have been demonstrated. 1 As a result, different studies of modications of the steroidal A, B and D rings, including the incorporation of heteroatoms or heterocyclic rings, have been reported. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Such systems enhanced the biological activities of these molecules, giving rise to a variety of antiproliferative, antimicrobial, anti-inammatory, hypotensive, hypocholesterolemic and diuretic activities. On the other hand, substituted thiosemicarbazone derivatives have attracted considerable attention due to their interesting biological activity. 14 Compounds containing a thiosemicarbazone moiety are known to possess tranquilizing, 15 muscle relaxing, psychoanaleptic, hypnotic, [16] [17] [18] [19] antidepressant, 20 antimicrobial, 14, 21, 22 antiamoebic, 23 analgesic, anti-inammatory 24, 25 and cytotoxic activities. 26 Also, thiosemicarbazones are important compounds as possible ligands for metal complexes and for the synthesis of heterocyclic compounds. [27] [28] [29] [30] [31] [32] [33] [34] [35] Heterocyclic compounds, especially those containing S and N atoms, are of great importance in treating biological systems. 21 Among these, thiazole, thiazolidinone, and thiadiazoline are of great signicance because they constitute the structural frameworks of several naturally occurring alkaloids that show a wide range of pharmaceutical and industrial importance. 35 Our interest in the transformation of steroidal compounds has for quite some time been focused on modied steroids that contain heteroatoms, new functional groups or heterocyclic systems as a part of their skeleton. Within this research area, we have recently reported a few papers on the synthesis and biological activity of steroidal lactams, thiolactams, and several sulfur-and sulfur and phosphorus-containing compounds, including new steroidal dimers, 3-thiones, 3,17-dithiones, 1,2,4trithiolanes, and phosphorotrithioates, as well as 17-spiro-and 17-substituted-1,3,2-oxathiaphospholane-2-suldes. 8, [36] [37] [38] [39] The results mentioned above prompted us to prepare new modied A ring-and A and D ring-substituted derivatives from 3-oxo-a,b-unsaturated steroids. Here, we report the synthesis of new mono-and bis(thiosemicarbazones) and mono-and bis (1,3,4-thiadiazolines) derived from several androstene derivatives (androst-4-ene-3,17-dione, 19-norandrost-4-ene-3,17dione, androsta-4,9(11)-diene-3,17-dione, 11a-hydroxyandrost-4-ene-3,17-dione and pregn-4-ene-3,20-dione) and their biological activity.
Steroidal thiosemicarbazones are well known and have been prepared for many years, but still there are only a few studies that provide detailed information on steroidal thiosemicarbazone isomers and even fewer about 1,3,4-thiadiazolines. For these reasons, we considered it important to synthesize new examples and provide and discuss all their structural details. The main focus of the chemistry section in the present work is concentrated on detailed congurational analysis, in particular the determination of the Z/E conguration of the C(3)]N double bond in thiosemicarbazones and the absolute conguration at C(3) and C (17) in mono-and bis (1,3,4thiadiazolines) , which was conrmed by X-ray analysis.
In addition, amongst the steroidal thiosemicarbazones and thiadiazolines synthesized so far, a very small number of papers deal with their biological activity and most of these studies describe the antibacterial effect of such compounds (I-VIII) ( Fig. 1) , 14, 21, [40] [41] [42] [43] whereas only a few studies have been carried out on steroidal thiosemicarbazones and thiadiazolines as antitumor agents (IX-XV) (Fig. 2) . [44] [45] [46] [47] [48] [49] In a similar way, another goal of this work was to perform an extensive investigation of the in vitro cytotoxic activity of the newly synthesized steroid derivatives. These compounds were tested against six human malignant cell lines: cervical adenocarcinoma (HeLa), two breast cancer cell lines (MDA-MB-453 and MDA-MB-361), chronic myelogenous leukemia (K562), colon adenocarcinoma (LS174) and lung adenocarcinoma (A549) cells.
Also, their cytotoxic activity was tested against normal human lung broblasts MRC-5. Compounds that exerted the most pronounced cytotoxic action were further screened for cytotoxic activity against normal human peripheral blood mononuclear cells (PBMC), which were non-stimulated and stimulated to proliferate with the mitogen phytohaemagglutinin (PHA). The specic aim of the study in this respect was to get an insight into the mechanisms of the cytotoxic effects of the tested compounds. The molecular formula of 2a was deduced to be C 19 H 27 N 3 OS from ESI-TOF-MS, which showed that the molecular weight of 2a was 73 Da higher than the molecular weight of the parent 19norandrost-4-ene-3,17-dione (1a), which conrmed that compound 2a contained a thiosemicarbazone moiety.
In the IR spectrum of 2a, the absorption band for carbonyl at C-3 was missing but the C(17)]O absorption band at 1732 cm À1 was unchanged. In addition, new absorption bands at 1586 and 1497 cm À1 appeared, which were attributed to n(C]N) stretching vibrations, as well as additional sharp bands in the region of 3246-3422 cm À1 , which were due to n(N-H) stretching vibrations, and a strong band at 1284 cm À1 , which was ascribed to n(C]S), which all conrmed the formation of the desired thiosemicarbazone compound. The 1 H NMR spectrum of the mixture of isomers of 2a showed two singlets for H-4 at d 5.92 ppm and 6.19 ppm, respectively, and four broad singlets for the H 2 N protons at d 6.36 and 7.24 ppm for the (E)-and at d 6.31 and 7.22 ppm for the (Z)-isomer. The signals for H-N appeared as singlets at d 8.71 ppm and 8.90 ppm for the (E)-and (Z)-isomers, respectively. The 13 C NMR spectrum also revealed two sets of signals, which conrmed that the obtained compound exists in the form of two isomers. The characteristic signals were: d 121.4 ppm and 111.2 ppm (C-4), 150.5 ppm and 149.5 ppm (C-3), 153.2 ppm and 158.4 ppm (C-5) and 178.4 ppm and 178.3 ppm (C]S) for the (E)-and (Z)-isomers, respectively.
The absolute conguration was determined by analysis of the NOESY cross-peaks involving the amide proton from the hydrazone moiety. In the major isomer, the proton at d 8.71 ppm showed NOESY correlations with Ha-2 at 2.66 and Hb-2 at 2.07 ppm, which indicated the E conguration, whereas in the minor isomer the N-H proton at d 8.90 ppm showed a NOESY cross-peak with H-4 at 6.20 ppm, which corresponds to the Z conguration ( Fig. 3 ).
3,17-Bis(thiosemicarbazone) 3a also occurs as a mixture of two isomers. The molecular formula of 3a was deduced to be C 20 H 30 N 6 S 2 from ESI-TOF-MS, which showed that the molecular weight of this compound was 73 Da higher than the molecular weight of compound 2a, which indicated that compound 3a had one more thiosemicarbazone moiety. Also, in the IR spectrum of 3a the absorption bands for carbonyls at C-3 and C-17 were missing. Instead, all the characteristic absorption bands for thiosemicarbazones at 3421, 3240, 1583, 1496, and 1282 cm À1 appeared.
From the NMR spectral data it can be seen that the isomers 3a-E and 3a-Z differ in the conguration at the C(3)]N double bond, whereas at C-17 only one isomer was obtained.
The 13 C NMR spectrum of 3a conrmed the presence of 20 carbon signals and also revealed two sets of signals. The major differences in the spectral data of 3a compared with those of 2a were the loss of the carbonyl peak at d 222.4 ppm, which was previously assigned to C-17 and was replaced by a peak at d 167.0 ppm (C (17) ]N), and the presence of a new peak at d 178.7 ppm for another C]S group. The other characteristic signals were: d 121.3 ppm and 111.4 ppm (C-4), 150.7 ppm and 149.7 ppm (C-3), 153.1 ppm and 158.4 ppm (C-5) and 178.3 ppm and 178.2 ppm (C]S) for 3a-E and 3a-Z, respectively.
The 1 H NMR spectrum of 3a also contained two sets of signals: two singlets for H-4 at d 5.91 for the (E)-and 6.22 ppm for the (Z)-isomer, and two broad singlet pairs for the H 2 N protons from the hydrazone moiety at C-3 at d 6.50 and 7.26 ppm for the (E)-and d 6.45 and 7.23 ppm for the (Z)-isomer. The broad singlet pair for H 2 N from the thiosemicarbazone moiety at C-17 appeared at d 6.53 and 7.18 ppm for both isomers. The signals for the two H-N protons appeared as singlets at d 8.83 and 8.49 ppm for the (E)-isomer and at d 9.05 and 8.49 ppm for the (Z)-isomer. The NOESY cross-peaks between NH/Ha-2 and NH/Hb-2 conrmed the E conguration on the C(3)]N double bond in the major isomer of 3a. In both isomers, the hydrazone moiety at C-17 adopted the E conguration, which was conrmed by the NOESY correlations of NH (8.49 ppm) with Ha-16 (2.28 ppm) and Hb-16 (2.47 ppm) and the absence of any correlation with CH 3 -18. Moreover, inspection of Dreiding models suggests that steric repulsion between CH 3 -18 from the sterane skeleton and the thiosemicarbazone moiety at C-17 prevents the formation of the (Z)-isomer ( Fig. 4 ).
Almost the same patterns in the 1 H NMR and 13 C NMR spectra were observed for all the newly synthesized thiosemicarbazones 2a-e and 3a-e.
When thiosemicarbazones 2a and 3a as mixtures of both isomers (E and Z) were treated with acetylating agents in basic media, from each mixture a single new heterocyclic compound was isolated. Thus, thiadiazoline 4a was formed from the mixture of 2a and 3,17-bis(thiadiazoline) 5a from the mixture of 3a.
The molecular formula of 4a was deduced to be C 23 H 31 N 3 O 3 S from ESI-TOF-MS, which showed a peak at m/z 430.21581 (calculated for C 23 In the IR spectra new characteristic absorption bands appeared at 1618 (C]N) and 756 (C-S) cm À1 for compound 4a and at 1642, 1615 (C]N) and 722 (C-S) cm À1 for compound 5a, due to ring closure.
In the 1 H NMR spectra the absence of signals for the amino groups from the parent compounds 2a and 3a was evident. Furthermore, the N-acetyl protons of the thiadiazoline rings in both compounds were shown as singlets at d 2.11 and 2.19 ppm for 4a and at d 2.09, 2.12, 2.18 and 2.22 ppm for 5a. The signal for the alkenyl H-4 proton appeared at about d 5.60 ppm for both compounds, upeld from the resonance of the corresponding proton in the starting compounds 2a and 3a, which also indicated the absence of a conjugated imine moiety, which was present in thiosemicarbazones 2a and 3a. In addition, the axial proton at C-16 in compound 5a (in the a-position to the thiadiazoline ring at C-17) resonates separated downeld from the other ring protons at d 4.35 ppm, owing to the position of the thiadiazoline ring and the strong anisotropic effect of C]O in the acetyl moiety bound to N-3 00 .
In the 13 C NMR spectra compound 4a showed characteristic signals at d 141.1 ppm for C-5 0 and compound 5a at d 146.4 and 149.4 ppm for C-5 0 and C-5 00 , respectively, owing to (N]C-S), which indicated the cyclization of the thiocarbamoyl carbon. Also, the signals for C-3 in compound 4a at d 79.9 ppm and both C-3 and C-17 in compound 5a at d 81.3 and 94.0 ppm, respectively, were situated upeld from the resonances of the same carbon atoms in thiosemicarbazones 2a and 3a, which suggested the formation of spiro-thiadiazolines.
The combined use of HSQC, HMBC, COSY and NOESY (ROESY) spectra enabled the complete 1 H and 13 C assignment of thiadiazolines 4a and 5a (see Experimental section). However, that did not help us to determine the absolute conguration at C-3. Luckily, in the case of compound 4a we were able to obtain crystals that were suitable for X-ray analysis, which conrmed the structure and showed that the absolute conguration at C-3 was R ( Fig. 5 ).
In the case of 3,17-bis(thiadiazoline) 5a our attempts at growing crystals that were suitable for X-ray analysis failed.
Considering the fact that the conguration at C-3 is already known (by comparison of the spectral data with those of compound 4a and from its X-ray analysis), the conguration at C-17 was determined by detailed analysis of the NMR spectra as well as by the examination of Dreiding molecular models. In the absence of any COSY or NOESY interactions that include the Nacetyl protons of the thiadiazoline ring at C-17, the most helpful were the protons bonded to C-16 (d 31.0 ppm) at d 2.06 ppm and especially the other proton, which resonates separated down-eld from the other ring protons at d 4.35 ppm. This signal showed a NOESY correlation with both Ha-15 at d 1.76 and Hb-15 at d 1.42 ppm, as well as with the 18-Me group at d 0.95 ppm, and, according to the Dreiding models, was attributed to Hb-16. Because the apparent disparity in the 1 H NMR shis in the case of Hb indicates strong deshielding owing to the anisotropic effect of the C]O group from the acetyl moiety bound to N-3 0 , the conguration at C-17 in 5a must be R (Fig. 6 ).
The mechanism of heterocyclization that leads to the formation of steroidal 1,3,4-thiadiazolines has already been described. 21, 50, 51 It is proposed that the thiadiazoline ring is closed by the attack of the sulfur atom (which is a better nucleophile) of the thiosemicarbazone moiety on the steroidal sp 2 carbon, preferentially from the axial side, which enables the bulky NAc group to occupy the equatorial orientation, giving minimum steric hindrance and maximum stability. 51 Therefore, the formation of the 3R and 3R,17R compounds is preferred over that of their isomers.
In the same way, the structures of thiadiazolines 4a-e and 3,17-bis(thiadiazolines) 5a-d were conrmed by their characterization data.
The exception was 3,20-bis(thiadiazoline) 5e derived from 3,20-bis(thiosemicarbazone) 3e, which was obtained as a mixture of two diastereoisomers (20R and 20S, in the ratio of approximately 1.2 : 1, as deduced by comparing the peak areas of H-C(4) and the H 3 C-18 and H 3 C-19 methyl groups in the corresponding 1 H NMR spectrum) with different congurations at C-20. As we could not separate the isomers, in the absence of any NOESY correlations it was not possible to conrm the complete stereostructure. These difficulties were accompanied by possible rotation around the C(17)-C(20) axis, which was conrmed by inspection of the Dreiding models. In this case, there was no steric repulsion between the bulky NAc group and the sterane skeleton, so closure of the thiadiazoline ring could occur by the attack of the sulfur atom of the thiosemicarbazone moiety on the C-20 sp 2 carbon atom from either side, which enabled the formation of both isomers. Hydrogen atoms are depicted as spheres of arbitrary radius. Bond lengths (Å): S1 0 -C5 0 (5) , N-C5 0 ¼ 1.377 (4), N-C20 ¼ 1.342 (4), N3 0 -C22 ¼ 1.345 (4), O1-C17 ¼ 1.192 (7) , O2-C20 ¼ 1.210 (5), O3-C22 ¼ 1.234 (4) . Valence angles ( ): C5 0 -S1 0 -C3 ¼ 89.86 (13) , N3 0 -C3-S1 0 ¼ 102.01 (17) , C4-C3-C2 ¼ 111.2 (3). Torsion angles ( ): Molecular and crystal structure of 1,3,4-thiadiazoline 4a
The molecular structure of compound 4a is depicted in Fig. 5 , together with relevant structural data. The compound crystallizes in the non-centrosymmetric space group I4, and its absolute conguration was assigned unambiguously by reference to the known chirality of the steroid atoms. The steroidal core has a common structure, with rings B and C in chair conformations and the ve-membered ring D in an envelope conformation on C-14. The cyclohexene ring A adopts a half-chair conformation (torsion angle C3-C4-C5-C10 ¼ À1.5 (5) ) induced by the C4-C5 double bond (1.321 (5)Å). To this steroidal core, a thiadiazoline ring is attached at the C-3 position, thus forming a spiro system. The X-ray structural study revealed that this newly formed stereocenter has R conguration, with S1 0 in the axial and N3 0 in the equatorial position relative to ring A.
There are a few structurally characterized compounds that contain a six-membered carbon ring and a thiadiazoline ring fused in a spiro system, 34, 50, 52 but none of these is a steroid derivative. Generally, the thiadiazoline ring in 4a has virtually the same structural parameters as are found in literature data concerning compounds with 1,3,4-thiadiazoline rings. 34, 50, 52, 53 It slightly deviates from planarity, adopting an envelope conformation with C-3 as a pivot atom. The sulfur atom S-1 0 is asymmetrically bonded to two carbon atoms in a way that the bond with sp 2 -hybridized C-5 0 is shorter (1.739 (3)Å) than the bond with sp 3 -hybridized C-3 (1.852 (3)Å). The N4 0 -C5 0 distance (1.282 (4)Å) corresponds to a localized double bond. The only difference is the fact that in 4a the acetyl group at N-3 0 and the acetylamino group at C-5 0 are coplanar with the thiadiazoline (4) ), in contrast to other structures in which acetyl groups signicantly deviate from coplanarity with the ring (121 < |s(C5 0 -N4 0 -N3 0 -C22)| < 170 ). The reason for this is the absence of any steric hindrance in 4a, in contrast to that found in other structures.
From the crystallographic point of view, the crystal packing of the molecules reveals an interesting feature, namely, the acetylamino NH group acts as a hydrogen bond donor to the acetyl oxygen from a neighboring molecule in a geometrical arrangement where four molecules form a molecular ring with crystallographic fourfold symmetry ( Fig. 7 ). In this way, a supramolecular tetramer is formed, which is described by the R 4 4 (28) graph set. 54 The central void created by this arrangement is lled with disordered DMSO molecules.
Biological evaluation
Cytotoxic activity. Cytotoxic activity in vitro was tested against six human malignant cell lines: cervical adenocarcinoma HeLa, two breast cancer cell lines (originally estrogen receptor-negative and progesterone receptor-negative MDA-MB-453 cells and estrogen receptor-positive and progesterone receptor-positive MDA-MB-361 cells), chronic myelogenous leukemia K562 cells, colon adenocarcinoma LS174 cells and lung adenocarcinoma A549 cells. Also, cytotoxic activity was tested against normal human lung broblasts MRC-5 (Table 1) . Compounds 2a, 2b, 2c, 2e, 5a and 5d, which exerted the most pronounced cytotoxic activity, were further screened for cytotoxic activity against normal human peripheral blood mononuclear cells (PBMC), which were non-stimulated and stimulated to proliferate with the mitogen phytohaemagglutinin (PHA).
Against K562 cells, compounds 2a, 2b, 2c, 2e, 3a and 5a showed strong cytotoxic activity, with IC 50 values of 11.3, 6.7, 6.7, 10.7, 11.2 and 8.8 mM, respectively. Compounds 3b, 3c and 5d showed moderate activity, with IC 50 values of 28.1, 30.3 and 36.4 mM, whereas compounds 2d and 4a exhibited weak activity against this cell line at 51.1 and 75.7 mM, respectively. Towards cervical adenocarcinoma HeLa cells, compounds 2b, 2e and 5a exerted strong cytotoxic activity, with IC 50 values of 7.6, 8.9 and 7.8 mM, respectively, whereas compounds 2a, 2c, 3c and 5b were slightly less active, with IC 50 values of 18.1, 17.3, 14.3 and 21.2 mM, respectively. Compounds 3a, 3b, 5c and 5d showed moderate activity, with IC 50 values from 27.7 to 43.9 mM, whereas compounds 4a-e were almost inactive against this cell line.
Compounds 2b, 2c, 2e and 5a exhibited strong activity against MDA-MB-453 cells, with IC 50 values of 6.8, 6.9, 6.9 and 11.0 mM, respectively, whereas compounds 2a, 5b, 5c and 5d showed moderate activity, with IC 50 values from 18.0 to 44.4 mM. All the other compounds were practically inactive against this cell line. Towards the MDA-MB-361 cell line, compound 2e exerted strong cytotoxic activity, with an IC 50 value of 8.7 mM, whereas compounds 2b and 2c were less active, with IC 50 values of 20.7 and 18.7 mM, respectively. Compound 5d showed moderate activity, with an IC 50 value of 54.1 mM, whereas the other compounds tested were practically inactive. Towards colorectal adenocarcinoma LS174 cells, compounds 2e and 5a showed a strong dose-dependent cytotoxic effect, with IC 50 values of 9.2 and 12.6 mM, respectively, compounds 2b, 2c, and 5d moderate and compound 2a weak activity, with IC 50 values of 35.2, 26.2, 42.6 and 61.3 mM, respectively.
Against human lung adenocarcinoma A549 cells, compounds 2a, 2b, 2c, 2e and 5a exhibited activity that was comparable to, or slightly better than, cisplatin, with IC 50 values of 10.3, 8.9, 9.5, 8.6 and 20.6 mM, respectively. Their cytotoxic activity was higher against normal human fetal lung broblasts MRC-5, with IC 50 values of 7.7, 6.5, 7.2, 6.7 and 12.7 mM. However, cisplatin, a chemotherapy drug that is used to treat different types of cancer, including non-small-cell lung cancer, showed a similar lack of selectivity.
The results mentioned above indicate that of the examined malignant cell lines, K562 cells were the most sensitive to the cytotoxic action of the newly synthesized steroid derivatives, especially 2a-c, 2e, 3a, 5a and 5d. HeLa cells demonstrated high sensitivity to 2a-c, 2e, 3c, 5a, 5b and 5d, and MDA-MB-453 cells to 2b, 2c, 2e, 5a, 5b and 5d. A549 cells were very sensitive to the cytotoxic activity of 2a, 2b, 2c, 2e and 5a, whereas LS174 cells were sensitive to the activity of 2c, 2e and 5a. MDA-MB-361 cells showed the lowest sensitivity to all the investigated compounds except 2b, 2c and 2e (Table 1) .
By examining the IC 50 values in Table 1 , it can be concluded that thiosemicarbazones 2a, 2b, 2c and 2e (as well as cisplatin, which served as a positive control) exhibited the highest cytotoxic activities against all cell lines, which were much higher than those of the corresponding starting steroids 1a-e or thiosemicarbazide itself. Bis(thiosemicarbazones) 3a-e exhibited much lower activities, which suggested that the introduction of another thiosemicarbazone group was not appropriate for cytotoxic activity against almost all the examined cancer cell lines. This pointed to the fact that, in addition to the thiosemicarbazone moiety at C-3, for the activity of these compounds a substituent at C-17 was also responsible. In compounds 2a, 2b and 2c, this was the 17-oxo group and in compound 2e the 17-acetyl group, which both signicantly increased the activities of these compounds. However, it is well known that the activity of a new compound does not only depend on its functional groups but also on its threedimensional orientation. Because we are dealing with inseparable mixtures of isomers (Z and E), it is impossible from this perspective to say which one actually had a greater cytotoxic effect upon the cell lines used in this study, especially because there are not many literature data regarding this matter. The only available literature that can be applied to steroidal thiosemicarbazone isomers describes the difference in the cytotoxic activity of E-and Z-steroidal oximes 8, 49 and, according to these references, there were no signicant differences in antiproliferative activity between the isomers.
A comparison of the derivatives with spiro-1,3,4thiadiazoline rings indicates that the compounds with two spiro-1,3,4-thiadiazoline rings (5a-d) displayed more pronounced cytotoxicity than those with one (4a-e and 5e), which were practically inactive against all the tested malignant cell lines. Taking this into account, it can be concluded that the spiro heterocyclic substituent at the C-17 position, as well as the presence of the a,b-unsaturated thiosemicarbazone moiety at C-3, enhanced the activity of the tested compounds. If the type of steroidal moiety is considered, it is evident that 3-thiosemicarbazones 2a, 2b, 2c and 2e showed similar activities towards the majority of cell lines tested. The absence of the 19-methyl group, the substituent at C-17 (17-oxo or 17-COCH 3 ) or the degree of unsaturation of the parent steroids were observed not to alter the extent of cytotoxic activity signicantly. The exception was 11a-hydroxy-3-thiosemicarbazone 2d, which was practically inactive against all the tested malignant cell lines, which indicated that the substitution of a hydrogen atom by a proton-donating OH group in the 11a position led to a dramatic decrease in activity. This nding was supported by the results obtained for other 11a-hydroxy derivatives, compounds 3d and 4d-OH, which were also inactive. In contrast, the introduction of an OCOCH 3 group in the 11a position (compounds 2d-OAc and 4d-OAc) much improved the activity of these compounds. Regarding 3,17-bis(thiadiazolines), from the data presented in Table 1 it can be seen that compounds 5b, with an androstene moiety, and 5c, with D 9-11 unsaturation, showed good cytotoxic activity, but only against HeLa and MDA-MB-453 cell lines. Compound 5d, with an 11a-OCOCH 3 group, showed moderate activity against all the examined cell lines, whereas compound 5a, with a 19-norandrostene moiety, exhibited very good activity against all the cell lines except MDA-MB-361.
The anticancer potential of compounds 2a, 2b, 2c, 2e, 5a and 5d, which exhibited the most pronounced cytotoxic activity against all the examined cancer cell lines, was further examined against normal human non-stimulated and mitogen-stimulated PBMC. The tested compounds showed higher cytotoxic activities against K562, HeLa, MDA-MB-453, LS174 and A549 cells in comparison with normal non-stimulated and PHA-stimulated PBMC. The activity of compounds 2e, 5a and 5d was in most cases less pronounced against non-stimulated than against stimulated PBMC ( Table 2) .
The selectivity in the anticancer activity of compounds 5a and 5d was very high, especially against HeLa and K562 cell lines (Tables 3 and 4 ). In addition, compound 2a showed notably higher cytotoxic activity against K562 and A549 cells than towards normal PBMC.
In order to elucidate the mechanisms of the cytotoxic activity of the steroidal compounds, an examination of changes in the cell cycle of myelogenous leukemia K562 cells and human cervical adenocarcinoma HeLa cells treated with compounds 2a, 2b, 2c, 2e, 5a and 5d for 24 and 48 h was performed. Analysis of the changes in the cell cycle phase distribution of HeLa cells caused by these steroidal compounds applied at concentrations of IC 50 and 2IC 50 revealed a signicant time-and dosedependent increase in cells in the subG1 phase compared with control cells (Fig. 8) . At both tested concentrations, compounds 2a, 2b, 2c and 2e exerted to some extent a stronger apoptotic effect with respect to compounds 5a and 5d. Compound 5d applied at a concentration of 2IC 50 led to a signicant accumulation of HeLa cells in the S phase aer treatment for 24 and 48 h. The same effect of compound 5d on HeLa cells was observed aer treatment for 48 h at a concentration of IC 50 . Treatment of K562 cells with concentrations of IC 50 of the investigated steroid derivatives induced signicant time-dependent increases in cells in the subG1 phase with respect to the control cell sample (with the exception of compounds 2a and 5a aer exposure for 24 h). In addition, all the investigated compounds at a concentration of 2IC 50 triggered a signicant increase in the percentage of K562 cells in the subG1 phase aer exposure for 24 h and 48 h ( Fig. 9) .
To investigate the possible pro-apoptotic activity of the steroidal compounds 2a, 2b, 2c, 2e, 5a and 5d against cervical adenocarcinoma HeLa cells, morphological analysis was performed by uorescence microscopy of target cells stained with acridine orange-ethidium bromide and exposed for 24 h to these agents.
As can be seen in Fig. 10 , the investigated steroid derivatives at concentrations of 2IC 50 induced typical morphological hallmarks of apoptosis in exposed HeLa cellschromatin condensation, shrinkage of the nucleus and fragmentation of the nucleus, as well as orange-red stained cells in the late stages of apoptosis.
Identication of HeLa cells in different stages of apoptosis induced by the examined steroid derivatives was performed by ow cytometry aer staining with annexin V-FITC/PI. In Fig. 11 , for each cell sample the percentages of annexin V + /PI À early apoptotic cells, annexin V + /PI + late apoptotic/secondary necrotic cells and annexin V À /PI + dead cells are shown. Increased percentages of early apoptotic and end-stage apoptotic/ secondary necrotic HeLa cells were measured in the samples treated for 24 h with concentrations of 2IC 50 of compounds 2a, 2b, 2c, 2e, 5a and 5d in comparison with the control cell sample. In addition, there was an increase in the percentage of dead HeLa cells (annexin V À /PI + ) for each of the tested steroidal compounds.
For further mechanistic studies of the mode of cell death induced by the most active compounds 2a, 2b, 2c, 2e, 5a and 5d in cervical adenocarcinoma HeLa cells, the possible activation of caspase-3, caspase-8 and caspase-9 was investigated by using specic caspase inhibitors. The observed decrease in the percentages of subG1 HeLa cells pretreated with each of the caspase inhibitors and exposed to the tested compounds, in comparison with the percentages of subG1 cells in samples exposed only to the compounds, points to the pro-apoptotic activity of the compounds. All the tested steroidal compounds activate extrinsic and intrinsic apoptotic signaling pathways in HeLa cells (Fig. 12) .
To investigate the anti-angiogenic potential of the most active and selective steroid derivatives 2a, 2b, 2c, 2e, 5a and 5d, an endothelial cell tube formation assay was performed. When human endothelial EA.hy926 cells are plated on the surface of a Matrigel matrix, they begin to extend, connect and rearrange in order to form capillary-like tube structures and polygonal structures. 55 Representative photomicrographs of control EA.hy926 cells and cells exposed to sub-toxic concentrations of IC 20 of the tested compounds aer 20 h are shown in Fig. 13 . As can be seen, each of the investigated steroidal compounds showed the ability to decrease angiogenesis in vitro. Compound 5a exerted the strongest anti-angiogenic activity. Compound 2a also exhibited a remarkable anti-angiogenic effect, whereas compounds 2b, 2c, 2e and 5d were less effective in inhibiting angiogenesis, especially 5d, which exerted the weakest antiangiogenic action.
The brine shrimp test. In the brine shrimp test, general toxicity against nauplii of the brine shrimp Artemia salina was evaluated. This assay has been established as a safe, practical, and economic method for the determination of the bioactivity of synthetic compounds, 56 and is considered to show a good correlation with cytotoxicity tests. 57 Compounds 5a-d, which displayed high cytotoxicity against HeLa and MDA-MB-453, were also found to be the most active in the brine shrimp assay, whereas compounds 2a-e and 3a-e, as well as thiadiazolines 4a-e, were found to be less active ( Table 5 ).
These results indicate that the bis(thiadiazoline) structure enhances the activity of the newly synthesized compounds, but also that other structural requirements must obviously be satised.
Antimicrobial activity. The in vitro antimicrobial activity of all given compounds 2-5 was tested against Gram-positive bacteria: Staphylococcus aureus, Kocuria rhizophila, Clostridium sporogenes and Bacillus subtilis, Gram-negative bacteria: Escherichia coli, Proteus hauseri, Pseudomonas aeruginosa and Salmonella enterica, as well as against fungal species: Candida albicans, Saccharomyces cerevisiae and Aspergillus brasiliensis by an agar well diffusion method.
Almost all the compounds, except 3a-e, exhibited weak inhibitory activity against the Gram-positive bacteria C.
sporogenes and K. rhizophila and against the Gram-negative bacterium P. aeruginosa. In all cases, the inhibition zones were much smaller than those for amikacin ( Table 6 ). All the novel synthesized compounds, except 3e, were found to have very weak antifungal activity against A. brasiliensis.
Moreover, compounds 2b, 2e, 3c, 4b-e, 5b, 5d and 5e exhibited weak inhibitory activity against the other two fungi tested, C. albicans and S. cerevisiae (Table 7) .
Experimental

Chemistry
Removal of solvents was carried out under reduced pressure. Thin-layer chromatography (TLC) was performed using aluminium plates coated with silica gel 60 F 254 (Merck) and ash column chromatography (FCC) was performed on silica gel (0.040-0.063 mm, Merck). TLC spots were detected with 50% aq. H 2 SO 4 followed by heating. Melting points were determined on a WRS-1B digital melting point apparatus and are uncorrected. Optical rotations were measured in CHCl 3 , CH 3 OH, or CHCl 3 /CH 3 OH (3 : 1) using a Rudolph Research Analytical Autopol IV automatic polarimeter at 20 C. IR spectra were recorded on a PerkinElmer 1725X FT-IR spectrophotometer. NMR spectra were recorded on a Varian Gemini-200 spectrometer ( 1 H at 200 MHz; 13 C at 50 MHz) or a Bruker Avance 500 MHz spectrometer ( 1 H at 500 MHz; 13 C at 125 MHz) in DMSO, CDCl 3 and/or CD 3 OD at room temperature using SiMe 4 as internal standard, d in ppm, J in Hz. HRMS spectra were recorded on an Agilent 6210 LC ESI-MS TOF spectrometer. Androst-4-ene-3,17-dione, 19-norandrost-4-ene-3,17-dione, androsta-4,9(11)-diene-3,17-dione, 11a-hydroxyandrost-4-ene- 3,17-dione and progesterone were purchased from Galenika AD (Beograd) and were recrystallized from a suitable solvent.
General procedure for the synthesis of thiosemicarbazones and bis(thiosemicarbazones) Thiosemicarbazide (3.16 mmol or 6.3 mmol) was added to a solution of steroid (1a-e) (3.16 mmol) in dried ethanol (150 or 300 mL). The reaction mixture was reuxed for 5 h with stirring and monitored by TLC. The pH of the mixture was adjusted to $4.5 with CH 3 COOH (about 5 mL). Aer completion of the reaction, the solvent was removed under reduced pressure. The residue was crystallized or chromatographed by FCC using different solvents as eluents (the eluents and ratio are mentioned in each experiment). In all cases, the products were obtained as mixtures of two diastereoisomers (E and Z), which could not be separated. All spectra were recorded using these mixtures.
Mixture of 2a (E/Z 13 Further elution with toluene/EtOAc/MeOH (60/40/1) gave 3b (79.4 mg, 6.1%).
Mixture of 3b (E/Z). Starting with 860 mg androst-4-ene-3,17dione (1b), elution with toluene/EtOAc (8/2) gave 2b (115.5 mg, 10.6%). Further elution with toluene/EtOAc/MeOH (60/40/1) 2e  10  12  12  12  12  12  10  12  3a - Further elution with toluene/EtOAc/MeOH (50/50/2) gave 3d (88 mg, 10%). procedure 62 implemented in PLATON. The estimated number of electrons in void regions was calculated to be 120 per unit cell, which corresponds to approximately 3 DMSO molecules per unit cell. Analytical data on the chemical composition point to 4 DMSO molecules per unit cell.
The nal results of the crystal structure determination are summarized as follows. Molecular formula: C 23 
Biology
Cytotoxicity assay. For the evaluation of cytotoxicity, six human cancer cell lines were used: cervical adenocarcinoma HeLa, breast carcinoma MDA-MB-453, breast adenocarcinoma MDA-MB-361, chronic myelogenous leukemia K562, colon adenocarcinoma LS174, and lung carcinoma A549, and one normal human cell line, lung broblasts MRC-5. Experiments were performed according to previously described methods. 39 HeLa (2000 cells per well), MDA-MB-453 (3000 cells per well), MDA-MB-361 (10 000 cells per well), LS174 (7000 cells per well), A549 (5000 cells per well) and MRC-5 (5000 cells per well) were seeded into 96-well microtiter plates and 20 h later, aer cell adhesion, ve different concentrations of the tested compounds were added to the cells. Only nutrient medium was added to the cells in the control wells. K562 cells (5000 cells per well) were seeded 2 h before the addition of the compounds. Stock solutions of the compounds, prepared according to a previously described procedure, [37] [38] [39] were diluted with complete nutrient medium and applied to the target cells at various nal concentrations ranging from 6.25 mM to 100 mM or 12.50 mM to 200 mM. The nal DMSO concentration did not affect cell viability. Survival of the target cells was determined by an MTT test aer 72 h of continuous activity of the agents, according to the method of Mosmann, 67 which was modied by Ohno and Abe 68 and used in our previous studies. [37] [38] [39] Cisplatin was used as a positive control.
The isolation and treatment of peripheral blood mononuclear cells (PBMC) were carried out according to a previously reported method. 48 
Live subject statement
The authors state that all experiments were performed in compliance with the relevant laws and institutional guidelines. The cytotoxicity assays using PBMC were approved by the Ethics Committee of the Institute of Oncology and Radiology of Serbia.
Written informed consent was obtained from each healthy blood donor.
Cell cycle analysis. K562 and HeLa cells were treated with two concentrations of compounds 2a, 2b, 2c, 2e, 5a and 5d (at values of IC 50 and 2IC 50 determined aer treatment for 72 h for each cell line) for 24 and 48 h. Aer the mentioned incubation times, the cells were collected, washed and xed in 70% ethanol, according to standard protocol. 39, 69, 70 Cell cycle distribution data are presented as Xav AE S.D. of three independent experiments. The statistical signicance of differences between the control and treated cell samples was evaluated using one-way repeatedmeasures ANOVA with Dunnett's post test. Values of p below 0.05 were considered to be statistically signicant.
Morphological assessment of mode of cell death of HeLa. To examine the mode of cell death of HeLa induced by compounds 2a, 2b, 2c, 2e, 5a and 5d, morphological analysis was undertaken, as described elsewhere. 39, 69 FITC-annexin V/propidium iodide double staining assay. Determination of human cervical adenocarcinoma HeLa cells in the early and late stages of apoptosis was performed by ow cytometry using FITC-annexin V/propidium iodide staining. FITC-annexin V was a product of BD Biosciences Pharmingen™. In brief, HeLa cells (200 000 cells per well) were exposed to concentrations of double IC 50 of the tested steroidal compounds for 24 h. Aer treatment, the cells were harvested, stained with FITC-annexin V and propidium iodide according to the manufacturer's instructions, and analyzed on a FACSCalibur ow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Data are presented as mean AE S.D. of two independent experiments.
Identication of target caspases. To identify the caspases involved in the apoptotic pathways induced by compounds 2a, 2b, 2c, 2e, 5a and 5d in HeLa cells, the percentages of cells in the subG1 phase pretreated with caspase inhibitors were determined, as previously described by Matić et al. 69 The specic caspase inhibitors applied at a concentration of 40 mM were: Z-DEVD-FMK, a caspase-3 inhibitor, Z-IETD-FMK, a caspase-8 inhibitor and Z-LEHD-FMK, a caspase-9 inhibitor. The caspase inhibitors were purchased from R&D Systems (Minneapolis, USA). The compounds were applied to HeLa cells at concentrations that corresponded to double the values of IC 50 obtained aer treatment for 72 h.
Endothelial cell tube formation assay. Possible effects of compounds 2a, 2b, 2c, 2e, 5a and 5d on the inhibition of angiogenesis in vitro were examined by the tube formation assay on a human umbilical vein endothelial EA.hy926 cell line. 55 The assay was performed according to a previously described procedure. 71 In brief, 24-well plates were coated with 200 mL Corning® Matrigel® basement membrane matrix (Corning cat. number 356234). Suspensions of EA.hy926 cells (40 000 cells per 400 mL) were plated on top of each Matrigel-coated well. Then, 200 mL complete nutrient medium (Dulbecco's modied Eagle's medium with high glucose and 4 mM L-glutamine supplemented with 10% heat-inactivated FBS and 25 mM HEPES) was added to the control cell sample, while solutions in nutrient medium of the tested compounds were added to the other cell samples. The plates were incubated for 20 h at 37 C in an atmosphere of 5% CO 2 and humidied air. Photomicrographs of EA.hy926 cells were captured using an inverted phasecontrast microscope aer treatment for 20 h. In our experiment, the EA.hy926 cells were exposed to low sub-toxic concentrations of the investigated compounds (concentrations of IC 20 obtained by an MTT test aer treatment that lasted for 24 h): for compound 2a, the applied concentration was 3.5 mM, for compounds 2b, 2c and 2e the concentration was 10 mM, for compound 5a the concentration was 4.5 mM and for compound 5d the concentration was 60 mM.
The brine shrimp test. The brine shrimp test was performed against freshly hatched nauplii of Artemia salina. 57 The method was slightly modied by our team. 39 The compounds were dissolved in MeOH/CHCl 3 , then in various amounts (1.0-0.05 mg) applied to lter paper discs (8 mm diameter) and the solvent was evaporated. All samples were tested in triplicate. LC 50 was dened as the concentration of compounds that caused the death of 50% of nauplii.
Antimicrobial activity. Antibacterial activity was evaluated using four different strains of Gram-positive bacteria: Staphylococcus aureus (ATCC 6538), Kocuria rhizophila (ATCC 9341), Clostridium sporogenes (ATCC 19404), and Bacillus subtilis (ATCC 6633), and four different strains of Gram-negative bacteria: Escherichia coli (ATCC 25922), Salmonella enterica subsp. enterica serovar Enteritidis (ATCC 13076), Proteus hauseri (ATCC 13315) and Pseudomonas aeruginosa (ATCC 9027). Antibacterial activity was determined by the well diffusion method. 72 To each Petri dish (90 mm diameter), 22 mL nutrient agar (HiMedia, Mumbai, India) and 100 mL bacterial suspension (10 6 cells per dish) were added. A well with a diameter of 8 mm was then punched carefully using a sterile cork borer and 100 mL test substance (1 mg/100 mL DMSO) was added to each labeled well. Amikacin (30 mg/100 mL H 2 O) was used as a positive control, whereas 100 mL water and DMSO served as negative controls. The same procedure was repeated for different microorganisms. Aer the inoculation of the organisms, compounds and controls, the plates were incubated for 24 h at 37 C. Zones of inhibition were recorded in millimeters.
The fungi tested were: Candida albicans (ATCC 10231), Saccharomyces cerevisiae (ATCC 9763) and Aspergillus brasiliensis (ATCC 16404). Sabouraud dextrose agar (Torlak, Belgrade, Serbia) was prepared according to the manufacturer's instructions. Into each sterile Petri dish (90 mm diameter), 22 mL previously prepared agar suspension was poured and 100 mL fungi (10 5 spores per dish) was added. A well with a diameter of 8 mm was punched using a sterile cork borer. Into each well 100 mL test substance (1 mg/100 mL DMSO) was added. Nystatin (30 mg/100 mL DMSO) was used as a positive control, whereas 100 mL DMSO served as a negative control. The plates were incubated for 48 h at 24 C. Antifungal activity was determined by measuring the diameter of the inhibition zone.
Conclusions
In this study, a series of new steroidal mono-and bis(thiosemicarbazones) 2a-e and 3a-e were prepared and further subjected to ring closure by means of acetylating agents to afford the corresponding 1,3,4-thiadiazolines 4a-e and 5a-e in good yields.
All compounds were biologically evaluated. The results of our in vitro study may indicate the signicant anticancer potential of steroidal compounds 2a, 2b, 2c, 2e, 5a and 5d, owing to their strong antiproliferative and pro-apoptotic effects against malignant cell lines and the specicity to cancer cells of their activity. Among these novel steroid derivatives, the best anticancer properties were exhibited by compound 5a. The spiro heterocyclic substituent at the C-17 position, as well as the presence of an a,b-unsaturated thiosemicarbazone moiety at C-3, enhanced the activity of the tested compounds. Moreover, their low antimicrobial activities indicate the selective activity of these new substituted and heterocyclic steroid derivatives.
Further research is needed to investigate the molecular mechanisms of their anticancer activity, in addition to in vivo evaluation of their antitumor efficacy.
